LBX2 and neoplasm: In our study, bioinformatics predicted that LBX2-AS1 had a miR-4766-5p binding site, and further experimental verification indicated that miR-4766-5p functioned as a tumor suppressor in GC tissues and cells, this is consistent with previous studies on the role of miR-4766-5p in breast cancer [9].